U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271784) titled 'Establishment of a Prediction Model for Postherpetic Neuralgia' on Sept. 17.
Brief Summary: This prospective cohort study enrolled 300 herpes zoster (HZ) patients at varying disease stages (1 week to 3 months post-onset) to investigate predictors of postherpetic neuralgia (PHN). Comprehensive baseline data were collected, including demographic characteristics (age, sex, body mass index [BMI]), clinical comorbidities (hypertension, diabetes mellitus), disease-specific parameters (duration of zoster-associated pain [ZAP], dermatomal distribution, pregabalin dosage equivalents), and psychometric assessments using validated scales (Nume...